Our network
All of our events are only possible because of our network of speakers, advisors, partners and attendees who continue to help develop and inform our series, ensuring that we remain the industry's most premier and relevant innovation series.
Read more about the Drug Development community below
Featured Speakers
Insight into the market dynamics that are having the greatest impact on an industry is what drives our business and its this understanding that allows us to identify and secure the thought leaders who have a true 'vision' to offer. This is a small sample of some of those visionaries that are helping shape the future of drug development.
Adrienne Davenport
Claes Gustafsson
Debora Marks
Emily Wrenbeck
Gregory Stephanopoulos
Huimin Zhao
Jeremy Steflik
Jill Caswell
Dr. Jill Caswell is the Biology Team Leader within Almac’s Biocatalysis group. After obtaining a degree in Biochemistry Jill worked in the industry producing recombinant proteins in a variety of host organisms before obtaining a PhD in 2011 through an industrial collaboration with Queen’s University Belfast.
Jill’s career has focussed on recombinant enzyme expression as well as molecular biology techniques that enable enzyme engineering. She joined Almac’s Biocatalysis group in 2012 with 10 years of industry-relevant experience to bring to the biology team, helping to grow the enzyme engineering capabilities.
John McIntosh
For his PhD, John studied in Eric Schmidt’s laboratory at the University of Utah, where he studied the biosynthesis of the cyanobactin family of cyclic peptide natural products.
After finishing graduate school John was a postdoc in Frances Arnold’s laboratory at Caltech where he studied non-natural reactions of cytochrome P450s and other heme proteins.
John have been with Merck’s Small-Molecule Process Research and Development Department since 2015 where he has worked in the Biocatalysis and Protein Engineering groups. He is presently an associate principal scientist.
Justin English
Justin Siegel
Karim Beguir
Karim Beguir is the chief executive officer and co-founder of InstaDeep.
He helps companies come to grips with the latest AI breakthroughs and deploy them to improve efficiency and ROI.
As a graduate of France's Ecole Polytechnique and former program fellow at New York University's Courant Institute, Karim has a passion for teaching and using applied mathematics. He's also a Google developer expert and a mentor at Google for Startups Accelerator, and is a steering committee member of Deep Learning Indaba.
Karim is on a mission to democratize AI and make it accessible to a wide audience.
Katharina Neufeld
Kevin Yang
Maria Lucas
Pierre Gilles
Ryan Phelan
Toni Lee
Tyler Korman
Strategic Partners
From the market leading Drug Development and Design Companies to the most well respected CROs, CMOs, Consultants, M&A Advisors, Private Equity, Incubators, Accelerators and Distributors, our Strategic Partners continue to play a pivotal role in how we help shape the future of Drug Development. For more information on how to become a strategic partner, please visit our Marketing Solutions page
About Us
LEARN
from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
NOTE
down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
INVEST
both in your company growth and your own personal development by signing up to one of our events and get started.